Table S3 from Phase I Study of Oncolytic Virus VV1 as Monotherapy or in Combination with Avelumab in Patients with Relapsed Refractory Solid Tumors
Year: 2026
Type: other
Abstract: DLT definition VV1 combination therapy
Subfield: Genetics
Domain: Life Sciences
Open Access status: gold
OpenAlex ID: W7202209796
Cites:
Cited by:
Related to:
